These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 37303738)
1. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells. Stickler S; Rath B; Hochmair M; Lang C; Weigl L; Hamilton G Oncol Res; 2023; 31(1):13-22. PubMed ID: 37303738 [TBL] [Abstract][Full Text] [Related]
2. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer. Hamilton G; Rath B Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677 [TBL] [Abstract][Full Text] [Related]
3. Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype. Hamilton G; Hochmair M; Rath B; Klameth L; Zeillinger R Cell Adh Migr; 2016 Jul; 10(4):360-7. PubMed ID: 26919626 [TBL] [Abstract][Full Text] [Related]
4. Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance. Klameth L; Rath B; Hochmaier M; Moser D; Redl M; Mungenast F; Gelles K; Ulsperger E; Zeillinger R; Hamilton G Sci Rep; 2017 Jul; 7(1):5337. PubMed ID: 28706293 [TBL] [Abstract][Full Text] [Related]
5. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines. Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534 [TBL] [Abstract][Full Text] [Related]
6. Metastasis: Circulating Tumor Cells in Small Cell Lung Cancer. Hamilton G; Moser D; Hochmair M Trends Cancer; 2016 Apr; 2(4):159-160. PubMed ID: 28741567 [TBL] [Abstract][Full Text] [Related]
7. Overcoming resistance in small-cell lung cancer. Hamilton G; Hochmair MJ; Stickler S Expert Rev Respir Med; 2024 Aug; 18(8):569-580. PubMed ID: 39099310 [TBL] [Abstract][Full Text] [Related]
8. Expression of Proteolytic Enzymes by Small Cell Lung Cancer Circulating Tumor Cell Lines. Rath B; Klameth L; Plangger A; Hochmair M; Ulsperger E; Huk I; Zeillinger R; Hamilton G Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669448 [TBL] [Abstract][Full Text] [Related]
9. Significance of circulating tumor cells in lung cancer: a narrative review. Hamilton G; Rath B; Stickler S Transl Lung Cancer Res; 2023 Apr; 12(4):877-894. PubMed ID: 37197632 [TBL] [Abstract][Full Text] [Related]
11. Small cell lung cancer: circulating tumor cell lines and expression of mediators of angiogenesis and coagulation. Rath B; Plangger A; Klameth L; Hochmair M; Ulsperger E; Boeckx B; Neumayer C; Hamilton G Explor Target Antitumor Ther; 2023; 4(2):355-365. PubMed ID: 37205313 [TBL] [Abstract][Full Text] [Related]
12. Role of circulating tumor cell spheroids in drug resistance. Hamilton G; Rath B Cancer Drug Resist; 2019; 2(3):762-772. PubMed ID: 35582592 [TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients. Togo S; Katagiri N; Namba Y; Tulafu M; Nagahama K; Kadoya K; Takamochi K; Oh S; Suzuki K; Sakurai F; Mizuguchi H; Urata Y; Takahashi K Oncotarget; 2017 May; 8(21):34884-34895. PubMed ID: 28432274 [TBL] [Abstract][Full Text] [Related]
14. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy. Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335 [TBL] [Abstract][Full Text] [Related]
15. Gemcitabine inhibits the micrometastasis of non-small cell lung cancer by targeting the EpCAM-positive circulating tumor cells via the HGF/cMET pathway. Liao ZJ; Guo YH; Zhao Z; Yao JT; Xu R; Nan KJ Int J Oncol; 2014 Aug; 45(2):651-8. PubMed ID: 24867356 [TBL] [Abstract][Full Text] [Related]
16. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system. Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710 [TBL] [Abstract][Full Text] [Related]
17. Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulating Tumor Cells in Small Cell Lung Cancer. Pore M; Meijer C; de Bock GH; Boersma-van Ek W; Terstappen LW; Groen HJ; Timens W; Kruyt FA; Hiltermann TJ Clin Lung Cancer; 2016 Nov; 17(6):535-542. PubMed ID: 27363902 [TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma. Qi LN; Xiang BD; Wu FX; Ye JZ; Zhong JH; Wang YY; Chen YY; Chen ZS; Ma L; Chen J; Gong WF; Han ZG; Lu Y; Shang JJ; Li LQ Cancer Res; 2018 Aug; 78(16):4731-4744. PubMed ID: 29915159 [TBL] [Abstract][Full Text] [Related]
19. Powering single-cell genomics to unravel circulating tumour cell subpopulations in non-small cell lung cancer patients. Acheampong E; Morici M; Abed A; Bowyer S; Asante DB; Lin W; Millward M; Gray ES; Beasley AB J Cancer Res Clin Oncol; 2023 May; 149(5):1941-1950. PubMed ID: 35896898 [TBL] [Abstract][Full Text] [Related]
20. Improved detection by ensemble-decision aliquot ranking of circulating tumor cells with low numbers of a targeted surface antigen. Johnson ES; Anand RK; Chiu DT Anal Chem; 2015 Sep; 87(18):9389-95. PubMed ID: 26302174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]